Media Features
quadra Scope - "Immune system restoration to treat obesity and build muscle"
Aug 14, 2024 - Dr. Hans Keirstead is a renowned stem cell expert, serial entrepreneur, and the Chairman of Immunis, a quadraScope portfolio company. quadra Scope interviewed Dr. Keirstead about how Immunis is restoring immune system function with stem cell-derived secretomes to treat chronic inflammation, obesity, and muscle atrophy.
Prix Galien USA - 2024 Nominees for "Best Digital Health Solution," "Best Medical Technology," "Incubators, Accelerators and Equity," and "Best Startup"
Aug 13, 2024 - Immunis is honored as a nominee for Prix Galien's "Best Startup." It is remarkable for Immunis to be featured among a list of incredibly innovative and groundbreaking companies. We are humbled by this recognition and excitedly await for the Prix Galien Gala in NYC in November.
Sapio Podcast - "Stem Cells - Myth vs Reality with Hans Keirstead, PhD"
Jun 18, 2024 - For Episode 88 of the Sapio Podcast, Dr. Buck Joffrey discusses with Immunis Chairman, Dr. Hans Keirstead, the incredibly promising future for human cell-derived secretome therapies. The 1-hour special covers topics from stem cell basics to the potential benefits of secretomes in extending human healthspan, as well as the importance of careful FDA-regulation when creating novel therapies.
Modern Healthspan - "Rejuvenation With Exosomes & Stem Cell Secretomes"
Jun 14, 2024 - Modern Healthspan highlights four special guest experts on exosomes and the secretome. These amazing scientists and world innovators include Dr. Harold Katcher, Dr. Hans Keirstead, Dr. Paul Robbins and Dr. Ducan Ross. Collectively, they discuss how stem cells can be used in the rejuvenation of human health.
Modern Healthspan - "The Most Promising Rejuvenation Therapy Now In Clinical Trials"
May 15, 2024 - Dr. Keirstead was an invited guest on human health-focused podcast Modern Healthspan (~80K subscribers) to discuss Immunis’ promising investigational secretome therapy, IMMUNA, and the company's mission to reverse muscle atrophy.
Nature Biotechnology - "After obesity drugs’ success, companies rush to preserve skeletal muscle"
Mar 5, 2024 - Immunis is establishing a lead position in the muscle regeneration sector. In early March, Nature Biotechnology released a news article highlighting Immunis as one of the top companies making advancements towards sarcopenia therapies. The importance in reversing muscle atrophy has recently skyrocketed given the unintended consequence of popular anti-obesity drugs in causing significant muscle loss.
Irvine Standard - "This Irvine scientist, a trailblazer in stem cell research, hopes to cure cancer – and maybe even old age"
Feb 2024 - The Irvine Standard dedicated a full spread to celebrate Dr. Keirstead’s successful career in regenerative medicine. The City of Irvine recognizes Dr. Keirstead as an incredible trailblazer in stem cell research, highlighting his ongoing efforts to combat age-related diseases and extend human healthspan.
Longevity Investors Lunch Panel Discussion - "Unlocking the Secrets of Brain Longevity"
Jan 16, 2024 - This thought-provoking panel was hosted by the Longevity Investors Lunch in Davos, as part of the World Economic Forum. The discussion was moderated by Dr. Hans Keirstead, Chairman of the Board at Immunis. He skillfully guides the conversation on the intricacies of brain longevity with distinguished panel features by Rajiv Ahuja, Associate Director at the Milken Institute Future of Aging and Dr. Emil Kendziorra, Founder and CEO of Tomorrow Biostasis.
Biotechnology Innovation Organization - I Am Bio Podcast Episode with Chairman Dr. Hans Keirstead
Aug 3, 2023 - Hear what inspires our Chairman, Dr. Hans Keirstead, to develop biomedical innovations that strengthen our immune system. This special episode was filmed by the Biotechnology Innovation Organization for their "I am Bio" video series.
Longevity Insider - "The Secretome: A Revolutionary Approach to Age-Related Diseases"
Jun 18, 2023 - Longevity Insider highlights a review by Immunis' Sr. Scientific Communications Manager, Dr. Karissa Jade Muñoz. Dr. Muñoz discusses the history of secretome research, its advantages over traditional stem cell therapies, and its potential in improving human healthspan.
ABC New Radio, West Coast Business Review - Interview with Dr. Keirstead
Apr 12, 2023 - Dr. Keirstead was an invited speaker on ABC news radio’s West Coast Business Review Podcast. Host Dr. Bill Morris had Dr. Keirstead delve deep into the mission behind Immunis and the limitless applications of secretomes.
NextMed Health - "The Future of Regenerative Longevity - Dr. Hans Keirstead"
Mar 15, 2023 - What is the future of extending human healthspan? In his compelling talk at NextMed Health 2023, stem cell and regenerative medicine pioneer, Dr. Hans Keirstead, discusses how the stem cell 'secretome' can enable immunomodulation to address elements of ageing.
Klick Group - "Navigating Immune Engineering and New Treatment Development"
Mar 15, 2023 - At the NextMed Health Conference, Chairman Dr. Hans Keirstead was interviewed by Dr. Gautam Gulati from Klick Group to share how Immunis is navigating the world of aging and longevity research from an immune perspective.
quadraScope - "Targeting the immune system to extend healthspan – interview with Dr. Hans Keirstead"
Dec 14, 2022 - quadraScope's Dr. José Navarro-Betancourt interviews Dr. Hans Keirstead, an internationally known stem cell expert, serial entrepreneur, and Chairman of Immunis, a quadraScope portfolio company aiming to enhance the function of the immune system using human cell-derived secretomes.
UCI LiveWell Magazine - "UCI opens clinical trial of stem cell-derived therapy for knee arthritis"
Nov 29, 2022 - UCI published an interview in LiveWell magazine with Dr. Dean Wang, the primary clinical investigator of Immunis’ Phase 1/2a clinical trial. Dr. Wang discusses the revolutionary therapeutic potential of cellular secretomes in ameliorating age-related diseases like muscle atrophy associated with knee osteoarthritis and expresses his enthusiasm for Immunis’ clinical trial.
Sciinov Healthcare - "A Stem Cell-Derived Secretome Targeting Age-Acquired Immune Decline: Dr. Hans Keirstead"
Nov 1, 2022 - Dr. Hans Keirstead was an invited speaker at the Sciinov Conference, which aims to benefit attendees through networking amongst high-quality health experts. Please enjoy Dr. Keirstead's presentation on the mission of Immunis to reverse age-related diseases using human cell-derived secretomes.